No abstract available
MeSH terms
-
Angiotensin-Converting Enzyme Inhibitors / adverse effects*
-
Antihypertensive Agents / adverse effects*
-
Antiviral Agents / administration & dosage
-
Antiviral Agents / adverse effects*
-
Cough / chemically induced*
-
Cough / genetics
-
Cough / physiopathology
-
Drug Substitution
-
Drug Therapy, Combination
-
Hepatitis C, Chronic / drug therapy*
-
Humans
-
Hypertension / drug therapy*
-
Interferon-alpha / administration & dosage
-
Male
-
Middle Aged
-
Polyethylene Glycols / administration & dosage
-
Recombinant Proteins / administration & dosage
-
Ribavirin / administration & dosage
-
Ribavirin / adverse effects*
-
Risk Factors
Substances
-
Angiotensin-Converting Enzyme Inhibitors
-
Antihypertensive Agents
-
Antiviral Agents
-
Interferon-alpha
-
Recombinant Proteins
-
Polyethylene Glycols
-
Ribavirin
-
peginterferon alfa-2a